Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023

Go back to Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023

Centessa Pharmaceuticals plc (CNTA) Tops Q2 EPS by 22c

August 14, 2023 7:14 AM EDT

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

... More